These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 23098858)

  • 1. Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis.
    Cotton CC; Baird D; Sandler RS; Long MD
    Inflamm Bowel Dis; 2016 Jul; 22(7):1631-8. PubMed ID: 27306071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease.
    Parks AL; Stevens SM
    Ann Intern Med; 2023 Dec; 176(12):JC143. PubMed ID: 38048580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls of pharmacoepidemiology.
    Skegg DC
    BMJ; 2000 Nov; 321(7270):1171-2. PubMed ID: 11073496
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions.
    Sandset PM
    J Thromb Haemost; 2006 Jan; 4(1):68-9. PubMed ID: 16409452
    [No Abstract]   [Full Text] [Related]  

  • 5. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
    Herzog C; Mall-Haefeli M
    Ther Ggw; 1979 Nov; 118(11):1722-44. PubMed ID: 395715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal contraception and venous thrombosis].
    Lidegaard Ø
    Ugeskr Laeger; 2013 May; 175(20):1401. PubMed ID: 23663393
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø
    Maturitas; 2013 Jan; 74(1):1-2. PubMed ID: 23098858
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.